Concourse Financial Group Securities’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10624 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10904 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10814 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10661 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10683 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 10812 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 10854 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 10932 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 10552 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 10555 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 10370 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 10153 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9910 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 9467 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8796 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8289 |
|